This approach improves detection and segmentation accuracy in brain tumor MRI images, suggesting enhanced efficiency and accuracy.
Brain tumors are highly malignant diseases that severely threaten the nervous system and patients’ lives. MRI is a core technology for brain tumor diagnosis and treatment due to its high resolution and non-invasiveness. However, existing YOLO-based models face challenges in brain tumor MRI image detection and segmentation, such as insufficient multi-scale feature extraction and high computational resource consumption. This paper proposes an improved lightweight brain tumor detection and instance segmentation model named FALS-YOLO, based on YOLOv8n-Seg and integrating three key modules: FLRDown, AdaSimAM, and LSCSHN. FLRDown enhances multi-scale tumor perception, AdaSimAM suppresses noise and improves feature fusion, and LSCSHN achieves high-precision segmentation with reduced parameters and computational burden. Experiments on the tumor-otak dataset show that FALS-YOLO achieves Precision (B) of 0.892, Recall (B) of 0.858, mAP@0.5 (B) of 0.912 in detection, and Precision (M) of 0.899, Recall (M) of 0.863, mAP@0.5 (M) of 0.917 in segmentation, outperforming YOLOv5n-Seg, YOLOv8n-Seg, YOLOv9s-Seg, YOLOv10n-Seg and YOLOv11n-Seg. Compared with YOLOv8n-Seg, FALS-YOLO reduces parameters by 31.95%, computational amount by 20.00%, and model size by 32.31%. It provides an efficient, accurate and practical solution for the automatic detection and instance segmentation of brain tumors in resource-limited environments.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: